Explore Business Standard
Associate Sponsors
Co-sponsor
)
At Bharat Mandapam, the India AI Impact Summit 2026 spotlights how AI is reshaping healthcare delivery, from digital records and teleconsultations to ethical, population-scale deployment
From warnings for expectant mothers to fears of harmful rays, here is what science actually says about eclipse-related health risks
Updated On: Feb 17 2026 | 10:39 AM ISTLong-acting medicines, including RNA-based therapies, may soon allow patients to manage high blood pressure with just two doses a year
Updated On: Feb 16 2026 | 5:55 PM ISTEven if longevity does not run in your family, following one of five healthy diets could meaningfully increase life expectancy, according to new research
Updated On: Feb 16 2026 | 3:45 PM ISTAn advancing of chronic kidney disease may be linked to an increase in cognitive impairment, such as problems with attention, processing speed and executive function, according to a study. The findings, published in The Journal of the American Medical Association (JAMA) Network Open, underscores that severity of chronic kidney disease could be a risk factor for cognitive decline. Chronic kidney disease is a long-term, progressive loss of kidney function -- where kidneys are not able to purify blood -- often lasting more than three months. Researchers, including those from Tulane University in the US, examined over 5,600 participants aged 21-79, analysing blood and urine samples for kidney function, and a cognitive function assessment for brain function over six years. "In this cohort study of 5,607 participants with CKD (chronic kidney disease), a higher urinary protein to creatinine ratio (in a urine test) was associated with impairments in attention and processing speed as well